Screener
Kiniksa Pharmaceuticals International, plc KNSA Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's asset turnover?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported asset turnover of 1.1× in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's asset turnover changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's asset turnover increased by 22.8% year-over-year, from 0.9× to 1.1×.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's asset turnover?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's asset turnover has grown at a 66.1% compound annual growth rate (CAGR), from 0.1× to 1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Kiniksa Pharmaceuticals International, plc's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude